Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Calaspargase pegol by Les Laboratoires Servier for Metastatic Pancreatic Cancer: Likelihood of Approval
Calaspargase pegol is under clinical development by Les Laboratoires Servier and currently in Phase I for Metastatic Pancreatic Cancer. According...